Deqsiga (Human Normal Immunoglobulin)

Deqsiga is a human normal immunoglobulin solution for intravenous use, designed to support immune system function. This product is manufactured by Takeda Manufacturing Austria AG and is sourced from the EU.

Deqsiga is used to provide passive immunity and support the immune system in various conditions. It is often administered to individuals with weakened immune systems or those who are at risk of infections. The primary use of Deqsiga is to help the body fight off infections and diseases by providing antibodies that can neutralize pathogens.

Common effects of Deqsiga may include mild to moderate infusion reactions such as headache, fever, chills, and nausea. These effects are generally temporary and subside after the infusion is completed. Some individuals may also experience fatigue or muscle aches.

Deqsiga should be administered under the supervision of a healthcare professional. It is important to monitor for any signs of allergic reactions or infusion-related side effects. Patients with a history of severe allergic reactions to immunoglobulin products should use this medication with caution.

Deqsiga may interact with certain medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking before starting Deqsiga. Additionally, caution should be exercised when combining Deqsiga with live virus vaccines, as the effectiveness of the vaccine may be reduced.